Pura Vida Investments’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Pura Vida Investments’s Portfolio MTACU Stock Details MTACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-103,944	Closed	-$1.04M	–	341
2021 Q2	$1.04M	Sell	103,944 -186,103	-64%	-$1.88M	0.03%	180
2021 Q1	$2.92M	Sell	290,047 -459,953	-61%	-$4.89M	0.08%	144
2020 Q4	$7.88M	Buy	+750,000	New	+$7.82M	0.29%	81

Other funds holding MTACU

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BCL

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

ZCA

Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Pura Vida Investments's MTACU Position: Q3 2021 in Review

Pura Vida Investments sold out of MedTech Acquisition Corporation Unit (MTACU) in Q3 2021, closing a stake of 103,944 shares — an estimated $1.04M sold.

Pura Vida Investments first reported a position in MTACU in Q4 2020 and held it in 3 quarters. The position peaked at $7.88M in Q4 2020. 20 funds tracked by Wall St. Rank hold MTACU as of Q3 2021.

Pura Vida Investments reported no remaining MedTech Acquisition Corporation Unit position as of Q3 2021 after selling out during the quarter.
Pura Vida Investments sold 103,944 MedTech Acquisition Corporation Unit shares in Q3 2021, an estimated $1.04M.
Pura Vida Investments first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 3 quarters.
Pura Vida Investments's MedTech Acquisition Corporation Unit position peaked at $7.88M in Q4 2020.
20 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q3 2021.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.